 Ahmed Abdelmoity
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 5 | 2023 | 7 | 2.540 |
Why?
| | Vagus Nerve Stimulation | 4 | 2023 | 6 | 1.910 |
Why?
| | Seizures | 5 | 2023 | 24 | 1.590 |
Why?
| | Epilepsy | 4 | 2023 | 14 | 1.240 |
Why?
| | Developmental Disabilities | 4 | 2017 | 42 | 1.060 |
Why?
| | Epilepsy, Absence | 2 | 2023 | 3 | 0.900 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2021 | 2 | 0.770 |
Why?
| | Humans | 21 | 2023 | 6929 | 0.710 |
Why?
| | Electroencephalography | 2 | 2019 | 7 | 0.700 |
Why?
| | Ketosis | 1 | 2019 | 2 | 0.680 |
Why?
| | Milk, Human | 1 | 2019 | 24 | 0.670 |
Why?
| | Retrospective Studies | 6 | 2021 | 1337 | 0.650 |
Why?
| | Brain | 1 | 2019 | 79 | 0.630 |
Why?
| | Child | 14 | 2022 | 3348 | 0.620 |
Why?
| | Child, Preschool | 10 | 2023 | 1562 | 0.610 |
Why?
| | Male | 12 | 2021 | 3367 | 0.590 |
Why?
| | Female | 11 | 2021 | 3534 | 0.580 |
Why?
| | Treatment Outcome | 4 | 2023 | 649 | 0.510 |
Why?
| | Adolescent | 7 | 2021 | 2183 | 0.480 |
Why?
| | Infant | 7 | 2023 | 1449 | 0.450 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2012 | 5 | 0.430 |
Why?
| | Nervous System Diseases | 1 | 2012 | 13 | 0.430 |
Why?
| | Congenital Abnormalities | 1 | 2012 | 17 | 0.430 |
Why?
| | Mental Disorders | 1 | 2012 | 16 | 0.420 |
Why?
| | Intellectual Disability | 1 | 2012 | 34 | 0.420 |
Why?
| | Anticonvulsants | 3 | 2023 | 27 | 0.390 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2010 | 5 | 0.380 |
Why?
| | Sequence Deletion | 1 | 2010 | 12 | 0.380 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 39 | 0.380 |
Why?
| | Mutation | 3 | 2017 | 213 | 0.290 |
Why?
| | Epilepsies, Partial | 2 | 2019 | 5 | 0.210 |
Why?
| | Comparative Genomic Hybridization | 2 | 2012 | 9 | 0.200 |
Why?
| | Exome | 3 | 2017 | 37 | 0.200 |
Why?
| | Rare Diseases | 1 | 2022 | 42 | 0.190 |
Why?
| | Phenotype | 3 | 2018 | 256 | 0.190 |
Why?
| | Combined Modality Therapy | 1 | 2021 | 47 | 0.190 |
Why?
| | Genomics | 1 | 2022 | 102 | 0.190 |
Why?
| | Sarcolemma | 1 | 2000 | 1 | 0.190 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 6 | 0.190 |
Why?
| | Muscle Proteins | 1 | 2000 | 6 | 0.190 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 13 | 0.190 |
Why?
| | Membrane Proteins | 1 | 2000 | 53 | 0.180 |
Why?
| | Cohort Studies | 2 | 2019 | 281 | 0.180 |
Why?
| | Tongue Diseases | 1 | 2019 | 1 | 0.180 |
Why?
| | Genome | 2 | 2022 | 33 | 0.180 |
Why?
| | Young Adult | 2 | 2019 | 641 | 0.170 |
Why?
| | Time Factors | 1 | 2020 | 263 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 2 | 2017 | 226 | 0.170 |
Why?
| | Sex Factors | 1 | 2019 | 68 | 0.160 |
Why?
| | Incidence | 1 | 2019 | 134 | 0.160 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 4 | 0.160 |
Why?
| | Phosphotransferases | 1 | 2017 | 2 | 0.150 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 7 | 0.150 |
Why?
| | Abnormalities, Multiple | 1 | 2017 | 36 | 0.150 |
Why?
| | Cadherins | 1 | 2016 | 7 | 0.140 |
Why?
| | Mosaicism | 1 | 2016 | 9 | 0.140 |
Why?
| | Incidental Findings | 2 | 2018 | 8 | 0.130 |
Why?
| | Family | 2 | 2018 | 27 | 0.130 |
Why?
| | Cholelithiasis | 1 | 2014 | 7 | 0.120 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2014 | 27 | 0.120 |
Why?
| | Adult | 2 | 2018 | 1199 | 0.110 |
Why?
| | Chromosome Duplication | 1 | 2012 | 3 | 0.110 |
Why?
| | Chromosome Deletion | 1 | 2012 | 21 | 0.110 |
Why?
| | DNA Mutational Analysis | 3 | 2017 | 43 | 0.100 |
Why?
| | Chromosome Breakage | 1 | 2010 | 1 | 0.100 |
Why?
| | Headache Disorders | 1 | 2010 | 3 | 0.090 |
Why?
| | Nervous System Malformations | 1 | 2010 | 6 | 0.090 |
Why?
| | Microcephaly | 1 | 2010 | 5 | 0.090 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2022 | 100 | 0.080 |
Why?
| | Sequence Analysis, DNA | 2 | 2022 | 116 | 0.080 |
Why?
| | Rho(D) Immune Globulin | 1 | 2008 | 1 | 0.080 |
Why?
| | Brain Infarction | 1 | 2008 | 1 | 0.080 |
Why?
| | Intracranial Thrombosis | 1 | 2008 | 3 | 0.080 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2008 | 4 | 0.080 |
Why?
| | Corpus Callosum | 1 | 2008 | 5 | 0.080 |
Why?
| | Ketone Bodies | 1 | 2023 | 2 | 0.060 |
Why?
| | Body Mass Index | 1 | 2023 | 156 | 0.050 |
Why?
| | Aged | 1 | 2023 | 411 | 0.050 |
Why?
| | Pedigree | 1 | 2022 | 61 | 0.050 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2000 | 2 | 0.050 |
Why?
| | Protein Transport | 1 | 2000 | 5 | 0.050 |
Why?
| | COS Cells | 1 | 2000 | 19 | 0.050 |
Why?
| | Luminescent Proteins | 1 | 2000 | 5 | 0.050 |
Why?
| | Green Fluorescent Proteins | 1 | 2000 | 11 | 0.050 |
Why?
| | Transfection | 1 | 2000 | 23 | 0.050 |
Why?
| | Calcium-Binding Proteins | 1 | 2000 | 10 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 14 | 0.050 |
Why?
| | Cell Line | 1 | 2000 | 79 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2000 | 56 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2023 | 826 | 0.040 |
Why?
| | Mice | 1 | 2000 | 339 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 37 | 0.040 |
Why?
| | Pakistan | 1 | 2018 | 5 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2018 | 5 | 0.040 |
Why?
| | Animals | 1 | 2000 | 741 | 0.040 |
Why?
| | Middle Aged | 1 | 2018 | 645 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 15 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2016 | 54 | 0.030 |
Why?
| | Base Sequence | 1 | 2014 | 87 | 0.030 |
Why?
| | Health Care Costs | 1 | 2014 | 31 | 0.030 |
Why?
| | Postoperative Period | 1 | 2014 | 18 | 0.030 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2014 | 38 | 0.030 |
Why?
| | Genome, Human | 1 | 2014 | 84 | 0.030 |
Why?
| | Radiography | 1 | 2010 | 49 | 0.020 |
Why?
| | Comorbidity | 1 | 2010 | 56 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 47 | 0.020 |
Why?
| | Neurology | 1 | 2010 | 10 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 45 | 0.020 |
Why?
| | Societies, Medical | 1 | 2010 | 50 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 104 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2010 | 333 | 0.020 |
Why?
| | Phlebography | 1 | 2008 | 7 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 77 | 0.020 |
Why?
| | United States | 1 | 2010 | 670 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|